BOSTON SCIENTIFIC CORP is 19.9x more valuable than HAEMONETICS CORP by market capitalization ($71.33 B vs $3.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HAE | BSX |
|---|---|---|
| Market cap | $3.58 B | $71.33 B |
| US-listed rank | #1668 | #239 |
| Revenue (latest FY) | $1.33B | $20.07B |
| Net income (latest FY) | $97.31M | - |
| Net margin | 7.3% | - |
| P/E (trailing FY) | 36.8 | - |
| SEC filings | 1,875 | 1,009 |
BOSTON SCIENTIFIC CORP is 19.9x more valuable than HAEMONETICS CORP by market capitalization ($71.33 B vs $3.58 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: HAEMONETICS CORP and BOSTON SCIENTIFIC CORP, or browse the full rankings.